Betaxolol Hydrochloride is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc. The primary component is Betaxolol Hydrochloride.
Product ID | 61314-245_68767c3b-6a83-4f6d-ab5b-af9cab31a08d |
NDC | 61314-245 |
Product Type | Human Prescription Drug |
Proprietary Name | Betaxolol Hydrochloride |
Generic Name | Betaxolol Hydrochloride |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2000-05-15 |
Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
Application Number | NDA019270 |
Labeler Name | Sandoz Inc |
Substance Name | BETAXOLOL HYDROCHLORIDE |
Active Ingredient Strength | 6 mg/mL |
Pharm Classes | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2000-05-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA authorized generic |
Application Number | NDA019270 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2000-05-15 |
Marketing Category | NDA authorized generic |
Application Number | NDA019270 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2000-05-15 |
Marketing Category | NDA authorized generic |
Application Number | NDA019270 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2000-05-15 |
Ingredient | Strength |
---|---|
BETAXOLOL HYDROCHLORIDE | 5.6 mg/mL |
SPL SET ID: | a73519d5-546c-4377-92ed-0d4be2685d60 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
10702-013 | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride |
10702-014 | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride |
61314-245 | Betaxolol Hydrochloride | Betaxolol Hydrochloride |
17478-705 | Betaxolol | Betaxolol Hydrochloride |
0065-0246 | Betoptic S | betaxolol hydrochloride |
0078-0729 | Betoptic S | betaxolol hydrochloride |